Quantcast
Last updated on June 2, 2012 at 14:15 EDT

News - Celtic Pharma

2011-10-03 07:00:00

NEW YORK, LONDON and HAMILTON, Bermuda, Oct. 3, 2011 /PRNewswire/ -- Celtic Pharmaceutical Holdings L.P.

2011-02-07 07:00:00

LONDON, NEW YORK and HAMILTON, Bermuda, Feb. 7, 2011 /PRNewswire/ -- Celtic Pharmaceutical Holdings L.P.

2010-10-21 07:00:00

NEW YORK, LONDON and BERMUDA, Oct. 21 /PRNewswire/ -- Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept® with Avastin®.

2010-04-30 07:00:00

LONDON, NEW YORK and HAMILTON, Bermuda, April 30 /PRNewswire/ -- Celtic Pharmaceutical Holdings L.P.

2010-04-22 07:00:00

NEW YORK, LONDON and HAMILTON, Bermuda, April 22 /PRNewswire/ -- Celtic Pharmaceutical Holdings L.P.

More News (23 articles) »